Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W7331692', 'doi': None, 'title': '[Comparative antiplatelet efficacy of prasugrel and high-dose clopidogrel in patients with coronary heart disease including acute coronary syndrome].', 'display_name': '[Comparative antiplatelet efficacy of prasugrel and high-dose clopidogrel in patients with coronary heart disease including acute coronary syndrome].', 'publication_year': 2012, 'publication_date': '2012-01-01', 'ids': {'openalex': 'https://openalex.org/W7331692', 'mag': '7331692', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22839447'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22839447', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090818231', 'display_name': 'Iakov Pakhomov', 'orcid': 'https://orcid.org/0000-0002-5566-1258'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Ia M Pakhomov', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5090818231'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '52', 'issue': '3', 'first_page': '82', 'last_page': '5'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 0.9664, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 0.9664, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/loading-dose', 'display_name': 'Loading dose', 'score': 0.8125088}, {'id': 'https://openalex.org/keywords/maintenance-dose', 'display_name': 'Maintenance dose', 'score': 0.7640815}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.52079904}, {'id': 'https://openalex.org/keywords/timi', 'display_name': 'TIMI', 'score': 0.41507134}], 'concepts': [{'id': 'https://openalex.org/C2777028646', 'wikidata': 'https://www.wikidata.org/wiki/Q416232', 'display_name': 'Prasugrel', 'level': 4, 'score': 0.9907683}, {'id': 'https://openalex.org/C2777849778', 'wikidata': 'https://www.wikidata.org/wiki/Q410237', 'display_name': 'Clopidogrel', 'level': 3, 'score': 0.9711642}, {'id': 'https://openalex.org/C35294091', 'wikidata': 'https://www.wikidata.org/wiki/Q6663385', 'display_name': 'Loading dose', 'level': 2, 'score': 0.8125088}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.78108627}, {'id': 'https://openalex.org/C27924281', 'wikidata': 'https://www.wikidata.org/wiki/Q17126475', 'display_name': 'Maintenance dose', 'level': 2, 'score': 0.7640815}, {'id': 'https://openalex.org/C2777698277', 'wikidata': 'https://www.wikidata.org/wiki/Q266018', 'display_name': 'Acute coronary syndrome', 'level': 3, 'score': 0.71982}, {'id': 'https://openalex.org/C49059817', 'wikidata': 'https://www.wikidata.org/wiki/Q14916330', 'display_name': 'P2Y12', 'level': 4, 'score': 0.65403163}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.55749124}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.52079904}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.50542927}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.45423833}, {'id': 'https://openalex.org/C2780890252', 'wikidata': 'https://www.wikidata.org/wiki/Q420542', 'display_name': 'Ticagrelor', 'level': 4, 'score': 0.4336744}, {'id': 'https://openalex.org/C2777995511', 'wikidata': 'https://www.wikidata.org/wiki/Q2897649', 'display_name': 'TIMI', 'level': 4, 'score': 0.41507134}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.33363488}, {'id': 'https://openalex.org/C500558357', 'wikidata': 'https://www.wikidata.org/wiki/Q12152', 'display_name': 'Myocardial infarction', 'level': 2, 'score': 0.17132989}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.1629703}, {'id': 'https://openalex.org/C2780400711', 'wikidata': 'https://www.wikidata.org/wiki/Q2008344', 'display_name': 'Percutaneous coronary intervention', 'level': 3, 'score': 0.0838176}], 'mesh': [{'descriptor_ui': 'D003327', 'descriptor_name': 'Coronary Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D010974', 'descriptor_name': 'Platelet Aggregation', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000077144', 'descriptor_name': 'Clopidogrel', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003327', 'descriptor_name': 'Coronary Disease', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D003327', 'descriptor_name': 'Coronary Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016903', 'descriptor_name': 'Drug Monitoring', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010974', 'descriptor_name': 'Platelet Aggregation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D010975', 'descriptor_name': 'Platelet Aggregation Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068799', 'descriptor_name': 'Prasugrel Hydrochloride', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058921', 'descriptor_name': 'Purinergic P2Y Receptor Antagonists', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D058921', 'descriptor_name': 'Purinergic P2Y Receptor Antagonists', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D058921', 'descriptor_name': 'Purinergic P2Y Receptor Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D013988', 'descriptor_name': 'Ticlopidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22839447', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W7331692', 'https://openalex.org/W4225135618', 'https://openalex.org/W3176979830', 'https://openalex.org/W3146448679', 'https://openalex.org/W3109162736', 'https://openalex.org/W3108239881', 'https://openalex.org/W2750112781', 'https://openalex.org/W2284874790', 'https://openalex.org/W1995254525', 'https://openalex.org/W1971044611'], 'abstract_inverted_index': {'A': [0, 85], 'number': [1], 'of': [2, 12, 16, 22, 36, 89, 106, 112, 121], 'randomized': [3], 'double-blind': [4], 'studies': [5], 'have': [6, 130], 'been': [7], 'conducted': [8], 'for': [9], 'comparative': [10], 'assessment': [11], 'the': [13, 63, 101], 'pharmacodynamic': [14], 'properties': [15], 'high': [17, 71], 'loading': [18, 26, 40, 102, 122], 'and': [19, 28, 33, 42, 66, 80, 91, 124], 'maintenance': [20, 31, 45, 126], 'doses': [21], 'clopidogrel': [23, 90, 113], '(600-900': [24], 'mg': [25, 30, 39, 44], 'dose': [27, 35, 41, 72], '150': [29], 'dose)': [32, 46], 'standard': [34], 'prasugrel': [37, 74, 92, 107], '(60': [38], '10': [43], 'in': [47], 'patients': [48], 'with': [49, 55, 70], 'coronary': [50, 57], 'heart': [51], 'disease,': [52], 'including': [53], 'those': [54, 111], 'acute': [56], 'syndrome.': [58], 'This': [59, 128], 'review': [60], 'briefly': [61], 'discusses': [62], 'trials': [64], 'ACAPULCO': [65], 'PRINCIPLE-TIMI': [67], '44.': [68], 'Compared': [69], 'clopidogrel,': [73], 'inhibited': [75], 'P2Y12-mediated': [76], 'platelet': [77], 'aggregation': [78], 'faster': [79], 'to': [81], 'a': [82], 'greater': [83, 109], 'extent.': [84], 'difference': [86], 'between': [87], 'effects': [88, 105], 'emerged': [93], 'as': [94, 96], 'soon': [95], 'at': [97], '30': [98], 'minutes': [99], 'after': [100, 119], 'dose.': [103], 'Antiplatelet': [104], 'were': [108], 'than': [110], 'both': [114], 'during': [115, 125], 'first': [116], '2-4': [117], 'hours': [118], 'administration': [120], 'dose,': [123], 'dosing.': [127], 'may': [129], 'important': [131], 'clinical': [132], 'implications.': [133]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W7331692', 'counts_by_year': [], 'updated_date': '2024-12-06T23:06:15.264347', 'created_date': '2016-06-24'}